Viewing Study NCT00039520


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-02-24 @ 3:15 PM
Study NCT ID: NCT00039520
Status: COMPLETED
Last Update Posted: 2014-05-06
First Post: 2002-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Sponsor: Fox Chase Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module